Drug and Medical Device Litigation

Thursday, December 14, 2006

About

Drug & Medical Device Litigation is the must-attend products liability conference for the pharmaceutical and medical device industries. Every year, hundreds of your colleagues gather in New York to network and hear from top-notch, senior faculty on the latest enforcement trends, emerging plaintiffs' theories, and advice on what works in the courtroom. This publication is a collection of presentations given at the conference.

Contents & Contributors

About

Drug & Medical Device Litigation is the must-attend products liability conference for the pharmaceutical and medical device industries. Every year, hundreds of your colleagues gather in New York to network and hear from top-notch, senior faculty on the latest enforcement trends, emerging plaintiffs' theories, and advice on what works in the courtroom. This publication is a collection of presentations given at the conference.

Contents & Contributors


LESSONS LEARNED FROM RECENT MASS TORT LITIGATION
J. Carter Thompson, Jr., Butler, Snow, O'Mara, Stevens & Cannada, PLLC (Jackson, MS)

A TACTICAL GAME PLAN FOR ACCOMPLISHING YOUR MDL GOALS
Lori G. Cohen, Greenberg Traurig, LLP (Atlanta, GA)

PROCEDURAL AND OTHER TRENDS UNDER THE CAFA "WHERE WE HAVE BEEN AND WHERE WE ARE GOING"
Paul E. Benson, Michael Best & Friedrich LLP (Milwaukee, WI)

STATE COURT MASS TORT CONSOLIDATION AND STATE/FEDERAL COORDINATION: WIN OR LOSS?
Diane E. Lifton, Gibbons (Newark, NJ)

NEW DEFENDANTS IN TRADITIONAL LITIGATION
James D. Pagliaro, Morgan, Lewis & Bockius LLP (Philadelphia, PA)

DEFENDING THE "NO INJURY" CLASS ACTION
Ezra D. Rosenberg, Dechert LLP (Princeton, NJ)

ALLIANCE OF ACTIVIST ATTORNEYS GENERAL AND THE PLAINTIFFS' BAR A GROWING TREND
Christopher C. Palermo, Kelley Drye & Warren LLP (New York, NY)

PERSPECTIVES ON PREPARING FOR PLAINTIFFS' NOVEL DAMAGE CLAIMS: NON-TRADITIONAL METHODS OF RECOVERY & THIRD-PARTY PAYOR RISKS
Joseph J. Leghorn, Nixon Peabody LLP (Boston, MA)
Tracey B. Ehlers, Nixon Peabody LLP (Buffalo, NY))

TAMING A MULTIHEADED BEAST: COORDINATING EXPERIENCE IN DIFFERENT ACTIONS
William W. Vodra, Arnold & Porter LLP (Washington, DC)
William J. Ruane, Wyeth (Madison, NJ)
Peter L. Zimroth, Arnold & Porter LLP (New York, NY)

LESSONS LEARNED FROM A FEW HUNDRED CRISES
Dan McGinn, The McGinn Group (Arlington, VA)

TRIAL ADVOCACY I: OPENING STATEMENTS, SCIENCE WITNESS EXAMINATION, AND JURY COMMUNICATION
Joseph K. Hetrick, Dechert LLP (Philadelphia, PA)
Bryan Harston, FTI Consulting (Dallas, TX)
Terry O. Tottenham, Fulbright & Jaworski L.L.P. (Austin, TX)

USING A MULTIDISCIPLINARY APPROACH TO MANAGE HIGH-STAKES LITIGATION TO THE BEST POSSIBLE OUTCOME
Joy Saphla, Huron Consulting Group (Houston, TX)

TAKING EFFECTIVE MEDICAL EXPERT AND FACT DEPOSITIONS
David Schrader, Morgan, Lewis & Bockius LLP (Los Angeles, CA)
Andrea Roberts, Baker & Daniels LLP (Indianapolis, IN)
C. K. "Pete" Rowland, Ph.D., Litigation Insights (Overland Park, KS)

EDUCATION OF SALES FORCE TO MINIMIZE EXPOSURE
Diane P. Sullivan, Dechert LLP (Princeton, NJ)

WITH FRIENDS LIKE THESE THE CHANGING ROLE OF MEDICAL JOURNALS IN PHARMACEUTICAL AND MEDICAL DEVICE LITIGATION
Peter J. Goss, Faegre & Benson LLP (Minneapolis, MN)

ASSESSING THE IMPACT OF MEDICAL AND SCIENTIFIC JOURNALS ON DRUG AND DEVICE LITIGATION- PART ONE (OF THREE)
Sean P. Wajert, Dechert LLP (Philadelphia, PA)

COMBATING THE MISLEADING USE OF MEDICAL AND SCIENTIFIC LITERATURE IN DRUG AND DEVICE LITIGATION
Stephen A. Wood, Kelley Drye & Warren LLP (Chicago, IL)

COMPREHENSIVE UPDATE ON THE FEDERAL PREEMPTION DEFENSE
Michael K. Brown, Reed Smith LLP (Los Angeles, CA)
Lisa M. Baird, Reed Smith LLP (Los Angeles, CA)
Mildred Segura, Reed Smith LLP (Los Angeles, CA)
Michelle H. Lyu, Reed Smith LLP (Los Angeles, CA)

THE 2006 LABELING RULE AND THE COURTS RECENT PREEMPTION DECISIONS
Vivian M. Quinn, Nixon Peabody LLP (New York, NY and Boston, MA)
Elizabeth A. Brophy, Nixon Peabody LLP (New York, NY and Boston, MA)

IDENTIFYING AND MINIMIZING LITIGATION RISKS OF CLINICAL TRIAL DATA AND POST-MARKET ADVERSE EVENT REPORTS
Harvey L. Kaplan, Shook, Hardy & Bacon L.L.P. (Kansas City, MO)
Catherine B. Levitt, Astellas US LLC (Deerfield, IL)
Sandra Phillips, Pfizer, Inc. (New York, NY)

DIRECT-TO-CONSUMER ADVERTISING: CURRENT DEVELOPMENTS AND THE LEARNED INTERMEDIARY DOCTRINE
John P. Lavelle, Jr., Ballard Spahr Andrews & Ingersoll, LLP (Philadelphia, PA)
Jason A. Leckerman, Ballard Spahr Andrews & Ingersoll, LLP (Philadelphia, PA)

OFF-LABEL ISSUES IN PHARMACEUTICAL AND MEDICAL DEVICE PRODUCT LIABILITY LITIGATION
Elizabeth B. Wright, Thompson Hine LLP (Cleveland, OH)

DIRECT-TO-CONSUMER ADVERTISING AND THE LEARNED INTERMEDIARY DOCTRINE
Tanya Dobash, Taro Pharmaceuticals U.S.A., Inc. (Hawthorne, NY)
John P. Lavelle, Jr., Ballard Spahr Andrews & Ingersoll, LLP (Philadelphia, PA)

THE PHARMACEUTICAL LANDSCAPE FOLLOWING THE 2006 ELECTIONS
Conan P. Grames, Pharmaceutical Research and Manufacturers of America (Washington, DC)

TRIAGE TIME LAST MINUTE PREPARATION FOR ELECTRONIC DISCOVERY UNDER THE NEW FRCP
Adam Cohen, FTI Consulting (New York, NY)
David J. Lender, Weil, Gotshal & Manges LLP (New York, NY)

MAKING THE DECISION TO SETTLE AND DEVISING NOVEL END-GAME STRATEGIES
Ellen K. Reisman, Arnold & Porter LLP (Los Angeles, CA)
Orran L. Brown, BrownGreer PLC (Richmond, VA)



DOCUMENT TYPES: PRESENTATIONS AVAILABLE: 0